scholarly journals Carotid angioplasty and stenting for postendarterectomy stenosis: Long-term follow-up

2007 ◽  
Vol 45 (1) ◽  
pp. 118-123 ◽  
Author(s):  
Gerrit J. de Borst ◽  
Rob G.A. Ackerstaff ◽  
Jean-Paul P.M. de Vries ◽  
Erik D vd Pavoordt ◽  
Jan Albert Vos ◽  
...  
Keyword(s):  
Carotid Angioplasty ◽  
Long Term Follow Up ◽  
Angioplasty And Stenting ◽  
Carotid Angioplasty And Stenting

Carotid Angioplasty and Stenting is a Safe and Durable Procedure in a Community Hospital

2007 ◽  
Vol 73 (6) ◽  
pp. 543-546
Author(s):  
Mark L. Friedell ◽  
Bryan J. Sandler ◽  
Joseph G. Andriole ◽  
Samuel P. Martin ◽  
Michael J. Cohen ◽  
...  
Keyword(s):  
High Risk ◽  
Community Hospital ◽  
Hospital Setting ◽  
Long Term Results ◽  
Carotid Angioplasty ◽  
Stroke Mortality ◽  
Angioplasty And Stenting ◽  
Carotid Angioplasty And Stenting

Carotid angioplasty and stenting (CAS) has been touted as a reasonable alternative to carotid endarterectomy (CEA) for high-risk surgical candidates. Several published CAS series, primarily from academic centers, show immediate results approaching those of CEA. However, very little is known about long-term results with CAS, particularly in the community hospital setting. Therefore, we retrospectively reviewed our CAS experience. From February 1999 to July 2003, 44 consecutive patients underwent placement of 46 stents. The mean patient age was 73 years, and 57 per cent were men. Most patients were asymptomatic (74%). High-risk categories included prior CEA (71%), other anatomic risks (13%), and/or significant medical comorbidities (16%). Technical success was achieved in all 46 cases. At 30 days, there were no deaths and one stroke, giving a combined stroke/mortality of 2 per cent. Clinical follow-up was obtained on all 44 patients at a mean follow-up of 42 months. Duplex scans performed on 44 stents (96%), at a mean follow-up of 40 months, demonstrated four 60 per cent to 79 per cent recurrent stenoses. CAS in a community hospital can have a 30-day stroke/mortality equivalent to CEA. The procedure is durable, with no critical (80%–99%) carotid restenoses and no stroke or transient ischemic attacks referable to a stented carotid artery in long-term follow-up.

scholarly journals Restenosis after carotid angioplasty and stenting: A follow-up study with duplex ultrasonography

2003 ◽  
Vol 26 (2) ◽  
pp. 141-144 ◽  
Author(s):  
M.H. Christiaans ◽  
J.M.P.G. Ernst ◽  
M.J. Suttorp ◽  
J.C. van den Berg ◽  
T.Th.C. Overtoom ◽  
...  
Keyword(s):  
Duplex Ultrasonography ◽  
Carotid Angioplasty ◽  
Follow Up Study ◽  
Angioplasty And Stenting ◽  
Carotid Angioplasty And Stenting

Carotid Angioplasty: Is it Safe?

1996 ◽  
Vol 3 (1) ◽  
pp. 35-41 ◽  
Author(s):  
Jean-Pierre Becquemin ◽  
Peter Qvarfordt ◽  
Yves Castier ◽  
Didier Melliere
Keyword(s):  
Carotid Artery ◽  
Balloon Angioplasty ◽  
Personal Experience ◽  
Neurologic Complications ◽  
Carotid Angioplasty ◽  
Review Of The Literature ◽  
Long Term Follow Up ◽  
Evolutionary Pace

For 15 years, balloon angioplasty has been cautiously applied to carotid artery occlusive lesions. Procedural results have, by and large, been satisfactory, but the potential for significant neurologic complications and a dearth of controlled studies with long-term follow-up have impeded the development of carotid angioplasty until recently. This review of the literature chronicles the slow but steady evolutionary pace of carotid angioplasty from its beginnings in 1980 to today's shifting focus to the use of stents. Based on these existing reports and significant personal experience, the advantages and risks of endoluminal carotid interventions are enumerated, along with suggested criteria for the application of carotid angioplasty.

Retinal Embolization During Carotid Angioplasty and Stenting: Periprocedural Data and Follow-Up

2009 ◽  
Vol 33 (4) ◽  
pp. 714-719 ◽  
Author(s):  
J. A. Vos ◽  
M. H. van Werkum ◽  
J. H. G. M. Bistervels ◽  
R. G. A. Ackerstaff ◽  
S. C. Tromp ◽  
...  
Keyword(s):  
Carotid Angioplasty ◽  
Angioplasty And Stenting ◽  
Carotid Angioplasty And Stenting

Restenosis after carotid artery stenting

Vascular ◽  
2017 ◽  
Vol 25 (6) ◽  
pp. 576-586 ◽  
Author(s):  
Zhengze Dai ◽  
Gelin Xu
Keyword(s):  
Carotid Stenosis ◽  
Influential Factors ◽  
Long Term Outcomes ◽  
Stent Restenosis ◽  
Common Etiology ◽  
Drug Eluting ◽  
Angioplasty And Stenting ◽  
Carotid Angioplasty And Stenting

As a common etiology for ischemic stroke, atherosclerotic carotid stenosis has been targeted by vascular surgery since 1950s. Compared with carotid endarterectomy, carotid angioplasty and stenting (CAS) is almost similarly efficacious and less invasive. These advantages make CAS an alternative in treating carotid stenosis. However, accumulative evidences suggested that the long-term benefit-risk ratio of CAS may be decreased or even neutralized by the complications related to in-stent restenosis (ISR). Therefore, investigating the mechanisms and identifying the influential factors of ISR are of vital importance for improving the long-term outcomes of CAS. As responses to intrinsic and extrinsic injuries, intimal hyperplasia and vascular smooth muscle cell proliferation have been regarded as the principle mechanisms for ISR development. Due to the lack of consensus-based definition and consistent follow-up protocol, the reported incidences of ISR after CAS varied widely among studies. These variations made the inter-study comparisons of ISR largely illogical. To eliminate restenosis after CAS, both surgery and endovascular procedures have been attempted with promising results. For preventing ISR, drug-eluting stents and antiplatelets have been proposed as potential solutions.

scholarly journals Safety and Efficacy of Flow Reversal in Acute and Elective Carotid Angioplasty and Stenting Using the Mo.Ma Device with Short-Term Follow-Up

2019 ◽  
Vol 8 (2-6) ◽  
pp. 196-205
Author(s):  
Ambooj Tiwari ◽  
Ryan Bo ◽  
Keithan Sivakumar ◽  
Karthikeyan M. Arcot ◽  
Philip Ye ◽  
...  
Keyword(s):  
Flow Reversal ◽  
Carotid Angioplasty ◽  
Short Term ◽  
Safety And Efficacy ◽  
Carotid Revascularization ◽  
Subacute Stroke ◽  
Angioplasty And Stenting ◽  
Carotid Angioplasty And Stenting ◽  
Radiographic Data

Objective: To determine the safety and efficacy of flow reversal following proximal flow arrest as an embolic protection strategy for carotid angioplasty and stenting (CAS) with short-term follow-up. Method: We performed a retrospective review of our CAS database for patients who underwent stent-supported carotid revascularization in the setting of acute/subacute stroke or TIA. We reviewed clinical and radiographic data during a 36-month period. Primary outcome was clinical evidence of ipsilateral stroke in the first 30 days. Secondary outcomes include clinical outcomes and sonographic and/or angiographic follow-up over 6 months, 6-month functional scale, and all-cause mortality. Results: Fifty-five patients underwent CAS using flow reversal: 26 females and 29 males with a mean age of 69.7 years. Median time to treatment from index event was 3 days. 11% underwent stenting as part of hyperacute stroke therapy. Average luminal stenosis was 86%. The 9-Fr Mo.Ma device was used in combination with Penumbra aspiration in all cases. There were no ipsilateral strokes. Incidence of any ischemic event was 3.64%, but only 1 (1.82%) patient had a postoperative stroke. Clinical follow-up was available for 94.5%, while lesion follow-up was available for 73% of patients. Three patients had evidence of restenosis, but none were symptomatic. Luminal restenosis was ≤30% in all three. Median pre- and post-NIHSS were 1 and 1, respectively. Conclusion: Flow reversal using the Mo.Ma device is a safe and effective strategy in preventing distal embolization during carotid artery revascularization.

Sign in / Sign up

Export Citation Format

Share Document